Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

REPL US Equity

Replimune Group, Inc.Health Care · Biological Products, (No Diagnostic Substances) · CIK 1737953 · FY ends Mar 31
$14.81
-0.77 (-4.94%)
USD · as of 2026-08-19 · marketstack